News
- Author:
- Roxanne Nelson, RN, BSN
Publish date: December 8, 2021
First oral SERD demonstrates statistically significant and clinically meaningful improvement in survival in patients with ER-positive/HER2-negative...
News
- Author:
- Roxanne Nelson, RN, BSN
Publish date: December 7, 2021
The results represent the longest median overall survival seen in a phase 3 trial of advanced melanoma.
News
- Author:
- Roxanne Nelson, RN, BSN
Publish date: November 18, 2021
Survey finds that physicians were not highly regarded as a source of information about cannabis use.
News
- Author:
- Roxanne Nelson, RN, BSN
Publish date: November 10, 2021
Adopting internal changes to system processes can eliminate racial disparities in cancer survival while improving survival for for all patients.
News
- Author:
- Roxanne Nelson, RN, BSN
Publish date: November 8, 2021
Stereotactic body radiation therapy proves to be beneficial for non–small cell lung cancer, but there was no benefit for breast cancer pa...
News
- Author:
- Roxanne Nelson, RN, BSN
Publish date: October 28, 2021
Brigatinib’s list price is $17,000 for a month’s treatment.
News
- Author:
- Roxanne Nelson, RN, BSN
Publish date: October 20, 2021
Although Pfizer claims that its pilot program is a first in the industry, there have been others that are similar.
News
- Author:
- Roxanne Nelson, RN, BSN
Publish date: October 19, 2021
Tramadol is widely used for noncancer pain but, as compared with codeine, it was associated with a higher risk for adverse outcomes, including deat...
News
- Author:
- Roxanne Nelson, RN, BSN
Publish date: October 18, 2021
“We feel that women considering implant-based reconstructions for breast cancer should be informed about the lack of evidence supporting its advant...
News
- Author:
- Roxanne Nelson, RN, BSN
Publish date: October 18, 2021
“We are unable to conclusively confirm that the tumour regression is due to the patient taking ‘CBD oil,’ ” the authors of the case report wrote.
News
- Author:
- Roxanne Nelson, RN, BSN
Publish date: October 14, 2021
The surgical oncologist apparently did not clearly communicate the situation to the rest of the clinicians involved in the patient’s care.
News
- Author:
- Roxanne Nelson, RN, BSN
Publish date: October 5, 2021
Gastric cancer patients treated within an integrated health care system had better outcomes, fewer complications, and increased overall survival, a...
News
- Author:
- Roxanne Nelson, RN, BSN
Publish date: September 30, 2021
The mainstay of therapy in this setting is monotherapy with chemotherapy, but the benefit-risk profiles are poor, and overall response rates are le...
News
- Author:
- Roxanne Nelson, RN, BSN
Publish date: September 16, 2021
Enfortumab vedotin is a first-in-class agent directed against cell adhesion molecule nectin-4 and is highly expressed in bladder cancer.
News
- Author:
- Roxanne Nelson, RN, BSN
Publish date: September 1, 2021
Proposals for a new mandatory payment model for radiation oncology have been met with strong pushbac...
